|
|
Volumn 330, Issue 1-2, 1997, Pages 3-5
|
|
Novel highly active thromboxane A2 synthase inhibitors devoid of carboxylic groups
a
|
|
Author keywords
17 hydroxylase C17,20 lyase (P450 17); antitumor drugs; aromatase (p450 arom); tetrahydroquinoline, imidazole substituted; thromboxane A2 synthase (P450 TxA2) inhibitors
|
|
Indexed keywords
5,7,8,9 TETRAHYDRO 5 [2 (1 IMIDAZOLYL)ETHYL]NAPHTHALENE;
5,7,8,9 TETRAHYDRO 5 [2 (1 IMIDAZOLYL)ETHYL]QUINOLINE;
AMINOGLUTETHIMIDE;
CYTOCHROME P450;
DAZOXIBEN;
THROMBOXANE B2;
THROMBOXANE SYNTHASE INHIBITOR;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL TISSUE;
ARTICLE;
CONTROLLED STUDY;
DRUG DESIGN;
DRUG SYNTHESIS;
ENZYME INHIBITION;
MICROSOME;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
PLACENTA;
PRIORITY JOURNAL;
RAT;
STRUCTURE ACTIVITY RELATION;
TESTIS;
|
|
EID: 0030934441
PISSN: 03656233
EISSN: None
Source Type: Journal
DOI: 10.1002/ardp.19973300102 Document Type: Article |
|
Times cited : (4)
|
|
References (14)
|
